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Abstract
Phosphatidylinositol binding clathrin assembly protein (PICALM), also known as clathrin assembly lymphoid myeloid
leukemia protein (CALM), was originally isolated as part of the fusion gene CALM/AF10, which results from the chromosomal
translocation t(10;11)(p13;q14). CALM is sufficient to drive clathrin assembly in vitro on lipid monolayers and regulates
clathrin-coated budding and the size and shape of the vesicles at the plasma membrane. However, the physiological role of
CALM has yet to be elucidated. Here, the role of CALM in vivo was investigated using CALM-deficient mice. CALM-deficient
mice exhibited retarded growth in utero and were dwarfed throughout their shortened life-spans. Moreover, CALM-deficient
mice suffered from severe anemia, and the maturation and iron content in erythroid precursors were severely impaired.
CALM-deficient erythroid cells and embryonic fibroblasts exhibited impaired clathrin-mediated endocytosis of transferrin.
These results indicate that CALM is required for erythroid maturation and transferrin internalization in mice.
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Introduction
Clathrin-coated vesicles mediate endocytosis of plasma mem-
brane receptors, channels, and transporters, as well as transmem-
brane proteins and various soluble macromolecules. As the main
component of clathrin-coated pits and vesicles, clathrin forms
structures termed triskelia, each composed of three heavy and
three light chains [1–5], which in turn assemble into a lattice-like
structure on the surface of coated pits. The major proteins that
drive coated pit formation are the adaptor protein complex AP-2
[1,6,7] and clathrin assembly proteins such as phosphatidylinosi-
tol-binding clathrin assembly protein (PICALM), also known as
clathrin assembly lymphoid myeloid leukemia protein (CALM).
The neuronal homolog of CALM, AP180, has been shown to be
sufficient for clathrin lattice assembly on lipid monolayers and for
the regulation of clathrin-coated buds and the size and shape of
vesicles at the plasma membrane [8–11].
CALM possesses an AP180 N-terminal homology (ANTH)
domain that binds to membrane lipids [9,12–15] and specific
motifs that bind to clathrin and AP-2, which are the primary
components of clathrin-coated vesicles [11,14,15]. Cellular
depletion of CALM by RNA interference results in the formation
of clathrin-coated structures of abnormal size and shape, which
suggests that CALM regulates the proper formation of clathrin-
coated vesicles [11].
CALM was originally isolated as a fusion gene, CALM/AF10,
which results from the chromosomal translocation t(10;11)(p13;q14).
This translocation is a cytogenetic abnormality found in acute
lymphoblastic leukemia, acute myeloid leukemia and in malignant
lymphomas [16]. In a murine bone marrow transplantation model,
expression of CALM/AF10 in primary murine bone marrow cells
results inthe development of an aggressiveformof leukemia [17,18].
These data suggest that CALM may play an important role in the
growth and differentiation of hematopoietic cells. This notion is
supported by reports that fit1 mutants, which contain nonsense point
mutations in the CALM gene, are anemic, display numerous
peripheral blood defects, and are deficient in early hematopoietic
progenitor cell populations [19–23]. Detailed analysis of the
hematopoietic defects of fit1 mutants has yet to be reported, and
so the physiological role of CALM remains elusive.
Using a genetic approach to elucidate the function of CALM in
mammals, we established CALM-deficient mice through gene
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remained dwarfed throughout their shortened life-span. In
addition, CALM-deficient mice suffered from severe anemia due
to ineffective erythropoiesis in the bone marrow. These pheno-
types resembled those of fit1 mutants. Moreover, the maturation
and iron content of erythroid precursors were severely impaired in
CALM-deficient mice. In addition, erythroid cells and murine
embryonic fibroblasts (MEFs) isolated from CALM-deficient mice
exhibited impaired clathrin-mediated internalization of transfer-
rin. These data collectively demonstrate that CALM is required
for erythroid maturation and transferrin internalization in mice.
Materials and Methods
Ethics Statement
This study received specific approval from the Committee of
Animal Experiments, Nara Women’s University (approval ID 06-
13).
Generation of CALM-deficient mice
A genomic clone encompassing the exon that contained the
initiation codon (methionine) of CALM was isolated from a
C57BL/6 BAC library (BACPAC) using Red/ET methods. A
targeting vector was constructed in which the marker gene PGK-
neo-pA was inserted into this exon. A DT-A fragment was ligated
to the 59 end of the targeting vector for negative selection. The
targeting vector was linearized by Sal I digestion and introduced
into TT2 embryonic stem (ES) cells by electroporation [24]. Of 96
G418-resistant clones, 22 were positive for homologous recombi-
nation, as determined by PCR (http://www.cdb.riken.jp/arg/
Methods.html), eight clones had undergone homologous recom-
bination as determined by Southern blot analysis. Three clones
were injected into 8-cell stage embryos. Chimeras were mated with
C57BL/6J females and germline transmission of the disrupted
CALM allele was confirmed. Heterozygous F1 mice were
intercrossed to produce homozygous CALM-deficient mice (Acc.
No. CDB0683K: http://www.cdb.riken.jp/arg/mutant%20mi-
ce%20list.html). Genotyping was carried out using PCR and
specific primers designed to amplify either the mutant or wild-type
allele. The sequences of the primers used for PCR analysis were as
follows: primer A: 59-ATGTCTGGCCAGAGCCTGACG-
GACCGAATC-39 and calm typing C: 59-GGGTCGGGAGAG-
GATGCGGGGGGTCTTCAC-39 for the wild-type allele; and
Neogt-1: 59-CTGACCGCTTCCTCGTGCTTTACG-39 and
calm typing C for the knockout allele.
Antibodies
For analysis by fluorescence-activated cell sorting (FACS), the
following antibodies were purchased from BD Pharmingen: anti-c-
Kit (2B8), -Sca-1 (D7), -TER119 (specific for erythroid lineage
cells), -Mac-1 (M1/70), -Gr-1 (RB6-8C5), -CD11c (HL3), -B220
(RA3-6B2), -CD44 (IM7), and -CD3e (145-2C11). For immuno-
histochemistry, an anti-transferrin receptor antibody was pur-
chased from Zymed. Alexa488-conjugated anti-mouse IgG was
obtained from Invitrogen. For immunoblot analysis, an anti-b-
actin antibody was purchased from Sigma, the anti-CALM
polyclonal antibody (G-17) was purchased from Santa Cruz, and
the horseradish peroxidase (HRP)-conjugated anti-mouse IgG and
anti-goat IgG antibodies were purchased from Thermo Fisher
Scientific.
Immunoblot Analysis
Immunoblot analysis was performed as described previously
[25]. Briefly, cells were lysed in SDS-PAGE sample buffer,
separated by SDS-PAGE, and then transferred to a nitrocellulose
membrane. The membranes were incubated in blocking buffer
(140 mM NaCl, 1 mM EDTA, and 20 mM Tris-HCl, pH 7.4)
containing 5% bovine serum albumin and 0.02% Tween 20,
followed by incubation for 1 h at room temperature with primary
antibody. Membranes were incubated with the appropriate
secondary antibodies diluted in blocking buffer, and then
immunoreactive proteins were visualized by enhanced chemilu-
minescence (GE Healthcare).
Flow cytometry
Flow cytometry were performed using a BD FACS Canto II
system (BD Biosciences). The data were analyzed using BD
FACSDiva software (BD Biosciences) or FlowJo software (TreeS-
tar, Ashland, OR).
Purification of murine Lin
2 Sca-1
+ c-Kit
+ (LSK) cells
Murine fetal liver (FL) cells were harvested from embryonic day
14.5 (E14.5) embryos and mononuclear cells (MNCs) were
obtained by density gradient centrifugation. MNCs were incubat-
ed with a cocktail of anti-lineage antibodies (Abs): biotinylated
anti-CD3e (145–2C11), -CD45R/B220 (RA3–6B2), -Gr-1 (RB6–
8C5), and -TER-119 (TER-119) Abs; fluorescein isothiocyanate
(FITC)-conjugated anti-Sca-1 (D7); allophycocyanin (APC)-conju-
gated anti-c-Kit (2B8); and streptavidin-PE-cy7 (BD Biosciences).
LSK cells were obtained by FACS using FACS Aria (BD
Biosciences). Staining with 7-amino-actinomycin D (Calbiochem)
was used to eliminate non-viable cells.
Hematopoietic stem cell (HSC) transplantation
LSK cells (1610
6) obtained from the fetal livers of CALM-
deficient and wild-type E14.5 embryos (CD45.2) were transferred
into irradiated (1.300 rad) recipients along with 1610
5 wild-type
LSK cells (CD45.1). The relative contributions from the
transferred HSCs were analyzed 9 weeks after transplantation.
Analysis of intracellular labile iron pool (LIP)
Cellular LIP was measured using the fluorescent metalosensor
calcein-AM(CA-AM; Invitrogen), as previously reported, with some
modifications [26,27]. Briefly, cells were incubated for 1 h with or
without 500 mM deferoxamine (DFO) (Sigma) in serum-free media
(a-MEM). Following washing with phosphate-buffered saline (PBS),
cells were incubated with 250 nM CA-AM for 10 min at 37uCi n
PBS,washedtwice,andthenresuspendedatadensityof1610
6/mL
in PBS containing 1% bovine serum albumin at room temperature.
In addition to CA-AM, as indicated, cells were also incubated with
APC-conjugated anti-TER119 and PE-conjugated anti-CD71 Abs.
Fluorescence intensity was measured using FACS Canto II (BD
Biosciences) in continuous mode. LIP was calculated as the
difference in CA mean fluorescence intensity between DFO-treated
and -untreated cells.
Image analysis
Microscopic images of May-Grunwald-Giemsa-stained periph-
eral smears were obtained using an Olympus (BX51) microscope
equipped with a digital camera (Olympus DP71) and processed
with DP Controller software.
CALM-deficient embryonic fibroblastoid cell lines
Primary MEFs were generated from mated wild-type or CALM-
deficient mice 14.5 days after conception. Primary MEFs were
immortalized by transfection with a plasmid containing SV40
genomic DNA. Briefly, primary MEFs were plated in six-well
Roles of PICALM in Erythropoiesis and Endocytosis
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2000 Reagent (Invitrogen, CA), according to the manufacturer’s
instructions. Stable immortalized cell clones were obtained by
serial dilution. The expression of CALM protein was assessed by
immunoblot. MEFs were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum (FCS)
and antibiotics (penicillin/streptomycin) at 37uC and 5% CO2.
Internalization assay
To evaluate the uptake of transferrin by erythroblasts, single cell
suspensions from fetal liver or bone marrow were incubated in
serum-free medium at 37uC for 2 h.
Cells were labeled with 50 mg/ml Alexa Fluor 647-conjugated
human transferrin (Invtrogen) in binding buffer (RPMI1640
containing 20 mM HEPES pH 7.4, 1% BSA) on ice for 30 min.
After washing to remove unbound transferrin, internalization of
transferrin was induced by incubating the cells in buffer
(RPMI1640 containing 10% fetal bovine serum) at 37uC for
various times. Any transferrin that remained bound to the plasma
membrane was removed by incubating the cells in pre-chilled
acidic buffer (20 mM MES pH 5, 130 mM NaCl, 50 mM
deforoxamine, 2 mM CaCl2 and 0.1% BSA) on ice for 20 min.
After washing three times, cells were labeled with FITC-
conjugated anti-TER119 Ab and the fluorescence intensity of
internalized transferrin in the erythroblast cell population
(TER119-high cells) was quantified by FACS Canto II (BD
Biosciences).
To detect the internalization of transferrin in MEFs, cells on
coverslips were incubated with 10 mg/ml Alexa Fluor 488-
conjugated human transferrin (Invitrogen) for 20 min at 37uC,
and then fixed with 3.7% formaldehyde in PBS for 15 min at
room temperature. After washing with PBS, cover slips were
mounted on glass slides using Prolong Gold (Invitrogen) and then
analyzed by spinning disc confocal microscopy (CSU10; Yoko-
gawa Electric Co.) using an inverted microscope (IX-71; Olympus)
equipped with an Ar/Kr laser, as described previously [25]. To
quantitate the internalization of transferrin in MEFs, the
fluorescence intensity of randomly selected individual cells (total
cell area) was measured and processed using Image J software
(http://rsbweb.nih.gov/ij/index.html).
Results
Generation of CALM-deficient mice
To address the functional role of CALM in mice, CALM-deficient
mice were generated using a gene targeting approach. The CALM-
targeting construct was designed with an expression cassette
containing the neomycin-resistance gene (neo
r) inserted just after the
initiation ATG codon in exon 1 of the CALM gene (Fig. 1A). Eight
clonal ES cell lines bearing the targeted allele were identified by
Southernblot analysis,of whichthree were used to generate chimeric
mice with germ line transmission of the targeted CALM allele. Their
offspring wereused for all studies reported herein. Heterozygous mice
exhibited no obvious abnormalities. To generate homozygous
CALM-deficient mice, F1 heterozygous mice were interbred and
the F2 offspring were genotyped by PCR and Southern blot (Fig. 1B
and C). The absenceof CALM protein expression in CALM-deficient
mice was confirmed by immunoblot (Fig. 1D).
CALM-deficient mice exhibit significant growth defects
and a shortened life-span
CALM-deficient mice were obtained at the expected Mendelian
ratios (Table 1). The CALM-deficient mice were smaller in size
compared to their wild-type littermates (Fig. 2A), and more than
90% died between birth and weaning (Table 1). To characterize
the retarded growth phenotype of CALM-deficient mice in more
detail, the body weight of CALM-deficient mice and their wild-type
littermates was assessed. As shown in Figure 2B, CALM-deficient
mice weighed, on average, 35.3% (for males) and 39.7% (for
females) of the weight of normal littermates at weaning (28 days of
age). Because CALM-deficient mice exhibited a growth retardation
phenotype at birth, we also assessed whether CALM was necessary
for normal prenatal growth. The weight of CALM-deficient
embryos was compared to that of their wild-type littermates at
E14.5. CALM-deficient embryos were approximately 74% of the
size of normal littermates (data not shown), which suggested that
CALM is also required for normal prenatal growth. The phenotype
of CALM-deficient mice therefore was retarded growth in utero with
mice remaining dwarfed throughout their life-span.
It should be noted that after back-crossing five times with
C57B6/J mice, no CALM-deficient mice were obtained, which
suggested that CALM deficiency may result in a lethal phenotype
that is dependent on the genetic background of B6 and CBA mice.
CALM-deficient mice suffer from severe anemia
Many of the tissues in CALM-deficient mice, including liver,
kidney and tibia, were smaller compared to wild-type mice
(Fig. 2C, E). By marked contrast, however, the spleens of CALM-
deficient mice were larger than those of their wild-type littermates,
which was indicative of splenomegaly (Fig. 2D). Histologic
examination revealed that follicles were absent in the spleens of
CALM-deficient mice, which indicating a defect in the B cell
population. This was confirmed by FACS analysis, which was
consistent with impaired B cell maturation in the spleens of CALM-
deficient mice (data not shown). In addition, there were fewer bone
marrow cells in CALM-deficient mice and the isolated cell pellets
were pale in appearance (Fig. 2F), which suggested a defect in the
regulation of hematopoiesis. In fact, the number of TER119-
positive erythroid cells in the bone marrow of CALM-deficient
mice was significantly reduced compared to control littermates
(Fig. 2G). We also observed a ballooning and granular
degeneration of hepatocytes (data not shown), indicative of
hepatocyte damage. As shown in Table 2, the number of red
blood cells (RBCs) in CALM-deficient mice was significantly
reduced compared to control littermates, and the mice were
severely anemic, with dramatically lower hemoglobin levels.
Additionally, peripheral blood in CALM-deficient mice contained
hypochromic RBCs (Fig. 2H).
Maturation of erythroid cells is impaired in CALM-
deficient mice
To investigate whether the severe anemia in CALM-deficient
mice was due to defects in erythroid differentiation, the expression
of transferrin receptor 1 (CD71) and TER119 was analyzed by
FACS, which allows the different stages of maturation of murine
erythroblasts to be distinguished [28]. Bone marrow cells were
immunostained with FITC-conjugated anti-TER119 and PE-
conjugated CD71 Abs (Fig. 3A, C). A representative FACS
histogram is shown in Figure 3A. Region I of the histogram
(CD71
highTER119
low) represents the proerythroblast population or
immature erythroblasts. Region II (CD71
highTER119
high) repre-
sentsthebasophilicerythroblastpopulation.RegionIII(CD71
low-med
TER119
high) represents the polychromatic and orthochromatic
erythroblast populations, which are hemoglobin-producing cells,
and region IV (CD71
lowTER119
high) represents mature erythro-
cytes. This profile is known as Socolovsky’s plot. As shown in
Figure 3A and C, CALM-deficient mice had significantly fewer cells
in region II compared with their wild-type littermates. These results
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to immature erythroblast is impaired in CALM-deficient mice.
To confirm these results, we also analyzed the expression levels
of CD44 and TER119, the relative levels of which have been
shown to correlate with different maturation stages of murine
erythroblasts [29]. Bone marrow cells were subjected to immuno-
staining with FITC-conjugated anti-TER119 and APC-conjugat-
ed CD44 Abs (Fig. 3 B, D). As shown in Figure 3B and D, CALM-
deficient mice had significantly lower numbers of cells in region III
compared with their wild-type littermates, which supported the
idea that erythroid maturation from proerythroblast to immature
erythroblast is impaired in CALM-deficient mice.
These data collectively suggested that the maturation of
erythroid cells is severely impaired in CALM-deficient mice.
The erythroid defects in CALM-deficient mice are cell
autonomous
HSC activity was analyzed by transplantation assay. Fetal liver
cells from wild-type or CALM-deficient embryos (CD45.2) were
transplanted into X-ray irradiated host mice along with a one-
tenth fraction of wild-type cells (CD45.1) as a competitor. After 9
weeks, CD45.2-positive hematopoietic cells derived from CALM-
deficient embryos had repopulated the bone marrow at the same
rate as wild-type cells (Fig. 4A). However, after 12 weeks, impaired
maturation of early to late stage erythroblasts and abnormal
erythroid cells were observed only in host mice transplanted with
fetal liver cells from CALM-deficient embryos (Fig. 4B and C). The
Figure 1. Targeted disruption of the CALM gene. (A) Schematic of the targeting strategy used for disruption of the first coding exon of CALM. (B)
Southern hybridization analysis of DNA isolated from targeted mouse embryos. From left to right: 59 probe, 39 probe and neo probe, as shown in A.
(C) Genomic PCR analysis of DNA isolated from mouse tail. The genotypes are indicated above each lane. (D) Immunoblot analysis of stable MEF cell
lines from wild-type (+/+) and CALM-deficient (2/2) mouse embryos (E14.5). The expected molecular weights of CALM are 62 and 72 kDa (arrows).
Actin was used as a loading control.
doi:10.1371/journal.pone.0031854.g001
Table 1. Genotypes of intercrossed CALM
+/2 mice.
Stage +/+ +/2 2/2
P28 72 (69) 138 8 (69)
P0 23 (25) 50 8 (25)
E19.5 9 (9) 17 6 (9)
E18.5 16 (13) 26 12 (13)
E14.5 17 (15) 29 18 (15)
The total number of embryos or postnatal mice isolated for each genotype is
indicated, with values in parentheses indicating the number of embryos or
postnatal mice expected based on Mendelian distribution.
doi:10.1371/journal.pone.0031854.t001
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CD44 staining (data not shown).
In addition, host mice transplanted with fetal liver cells from
CALM-deficient embryos were anemic and had fewer RBCs and
lower hemoglobin levels than wild-type transplanted mice (data
not shown). These results indicated that the observed erythroid
defects in CALM-deficient mice were cell autonomous and not a
result of the hematopoietic environment.
It should be noted that host mice transplanted with fetal liver
cells from CALM-deficient embryos also exhibited splenomegaly,
and that there was a similar pattern of progenitor activity in spleen
cells as in bone marrow (data not shown). On the other hand, no
progenitor activity was detected in spleen cells from host mice
transplanted with fetal liver cells from wild-type embryos.
Incorporation of iron is reduced in erythroid cells of
CALM-deficient mice
Erythroid cells from CALM-deficient mice were severely anemic
and erythroid maturation was impaired (Fig. 2, 3 and 4). Since
iron deficiency is known to inhibit erythroid differentiation and
Figure 2. Growth retardation and peripheral blood morphology in postnatal CALM-deficient mice. (A) Wild-type (+/+) (left) and CALM-
deficient (2/2) (right) mice at 3 weeks of age. (B) Average weight of wild-type (+/+) and CALM-deficient (2/2) mice at postnatal day 28. Data shown
represent CALM-deficient males (n=3), CALM-deficient females (n=4), wild-type males (n=36), and wild-type females (n=35). **, P,0.01 vs control.
Liver (C), spleen (D) and tibia (E) from wild-type (+/+)o rCALM-deficient (2/2) mice at 3 weeks of age. (F) Bone marrow cells were collected by
centrifugation. Note that the pellet from CALM-deficient (2/2) mice is small and pale in color. (G) Quantification of TER119-positive bone marrow
cells (data represent means6SD; n=5). *, P,0.05 vs. control. (H) Peripheral blood smears from wild-type (+/+) littermates (left panels, a and c) or
CALM-deficient (2/2) mice (right panels, b and d) at 3 weeks of age. Magnification: upper panels, 4006; lower panels, 10006. Scale bar, 50 mm
(upper panel) and 20 mm (lower panel).
doi:10.1371/journal.pone.0031854.g002
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in erythroid cells in CALM-deficient mice was the cause of the
anemia.
Iron bound to transferrin is taken up by cells via transferrin
receptor 1-mediated endocytosis. This is the main pathway of iron
intake in erythroid cells. We first analyzed amount of ferritin and
transferrin in the plasma of wild-type and CALM-deficient mice by
ELISA (ICL, Portland, OR, USA). There were no differences in
the levels of transferrin in wild-type and CALM-deficient mice,
whereas ferritin levels, which directly correlate with the total
amount of iron stored in the body, were three-times higher in
CALM-deficient mice than wild-type mice. These results suggested
that there was an excess of iron in the body of CALM-deficient
mice, despite the hypochromic and microcytic anemic phenotype.
This suggested that there was an imbalance in the distribution of
iron from erythroid cells to other tissues in CALM-deficient mice.
To investigate this possibility, we examined the labile (or
chelatable) iron pool (LIP) in erythroid cells, which is a point of
convergence of the iron metabolic pathways. The LIP was
measured using the cell permeable iron chelator CA-AM, as
previously described [26,27]. Upon uptake by viable cells, CA-AM
undergoes hydrolysis by esterases to form calcein (CA), the
fluorescence of which can be measured (excitation wavelength of
488 nm, emission wavelength of 517 nm). CA fluorescence is
quenched upon binding to the cellular LIP in a stoichiometric
fashion. The presence of a high-affinity chelator such as
desferoxamine (DFO) results in extraction of iron from CA-iron
complexes and a corresponding increase in CA fluorescence.
Thus, the difference in cellular fluorescence in the presence and
absence of DFO can be taken as a measure of the LIP. The LIP is
dependent on cell type and maturation stage; analysis of erythroid
cells in the blood, bone marrow and in culture has shown that the
LIP decreases during maturation [26,27]. Compared to wild-type
cells, erythroid cells in the bone marrow of CALM-deficient mice
exhibited higher CA fluorescence intensity in regions I through III
of the Socolovsky plot (Fig. 5A, B). As shown in Fig. 5C and D, the
mean fluorescence intensity (MFI) of CA-AM-loaded wild-type
fetal liver erythroid cells at stages I and II was 762 and 126,
respectively, and MFI was significantly increased to 1211 and 263,
respectively, by treatment with DFO. Based on the difference in
MFI in DFO-treated and -untreated cells, the LIP in wild-type
cells in stages I and II was 4846181 and 137617 (MFI6S.D;
n=7), respectively (Fig. 5E). On the other hand, in CALM-
deficient cells, there was only a small increase in CA fluorescence
in the presence of DFO, which suggested that the cellular LIP in
CALM-deficient cells was smaller than in wild-type cells. The LIP
also appeared to be relatively constant in CALM-deficient cells
(55676 and 39626 at stages I and II, respectively; n=3). Similar
results were obtained using bone marrow cells from host mice
transplanted with fetal liver cells from wild-type or CALM-deficient
embryos (data not shown).
Several reports show that CA is pumped out of cells via the
multidrug resistance machinery [32]. There were no apparent
differences in mean CA-fluorescence intensity in DFO-treated
wild-type and CALM-deficient cells, which indicated that there
were similar levels of CA in both cell types (Fig. 5 D). Thus, it is
unlikely that the differences in LIP were due to the multidrug
resistance machinery. Taken together, these results indicated that
the iron content of erythroid cells at stages I and II is lower in
CALM-deficient mice compared to their wild-type littermates.
Therefore, altered distribution of iron in CALM-deficient mice
inhibits erythroid maturation and results in anemia.
Reduced incorporation of transferrin into erythroid cells
and MEFs derived from CALM-deficient mice
Transferrinreceptor1,alsoknownasCD71,ishighlyexpressedin
erythroblasts, and uptake of iron-bound transferrin through
transferrin receptor 1 is the main pathway of iron uptake in
erythroid precursors [33,34]. It is also well established that inhibition
of this process inhibits erythroid maturation. Because transferrin is
internalized via clathrin-dependent endocytosis [6,35], and CALM
localizes to clathrin-coated pits, clathrin-mediated endocytosis of
transferrin in CALM-deficient mice was assessed [11,15].
Transferrin uptake by erythroid cells from fetal liver was assessed
by FACS, as described in Materials and Methods. The level of
transferrin receptor (CD71) expression in TER119-positive ery-
throid cells from CALM-deficient mice was about 2.5-fold higher
than that seen in wild-type cells (336561398 and 855461681
MFI6S.D,respectively;n=3),which could reflectdifferencesinthe
internalization of transferrin receptors. Thus, transferrin uptake was
normalizedtotransferrinreceptorlevelforthisanalysis.Inwild-type
cells, 62% of bound transferrin was rapidly internalized after 3 min.
On the other hand, only 19% of bound transferrin was internalized
by CALM-deficient cells (Fig. 6A). Similar results were obtained
using wild-type and CALM-deficient erythroid cells derived from
neonatal bone marrow (data not shown).
To examine this defect in transferrin internalization in more
detail, MEFs were established from wild-type and CALM-deficient
E14.5 embryos. Wild-type MEFs expressed the transferrin
receptor and transferrin was internalized in a constitutive manner
(Fig. 6B). However, CALM knock-out MEFs derived from CALM-
deficient embryos failed to incorporate transferrin (Fig. 6B),
despite similar overall levels of transferrin receptor (Fig. 6C).
Transferrin uptake in wild-type and CALM-deficient MEFs was
quantitated and the results are shown in Fig. 6D. Uptake of
transferrin by wild-type MEFs was approximately twice that seen
in CALM-deficient cells. These results indicated that the
internalization of transferrin receptors is abrogated in CALM-
deficient cells. Thus, the erythropoietic defects in CALM-deficient
mice may be due to inhibition of transferrin endocytosis in the
absence of CALM.
Table 2. Hematopoietic parameters of control and CALM
2/2 mice.
Genotype WBC RBC Hb HCT MCV MCH MCHC PLT
+/+ 3.760.98 875.3665.5 13.260.85 47.463.29 54.160.44 15.060.18 27.860.17 80.0654.45
+/2 2.360.49 840.0652.4 12.660.88 46.562.42 55.462.13 15.060.97 27.160.74 103.0629.90
2/2 3.460.90 267.8697.0 3.761.29 14.264.71 53.464.80 13.961.17 26.161.01 118.6623.34
Data were obtained from 3-week-old mice. WBC, white blood cell count (610
3/ml); RBC, red blood cell (610
4/ml); Hb, hemoglobin (g/dl); HCT, hematocrit (%); MCV, mean
corpuscular volume (fl); MCH, mean corpuscular hemoglobin (pg); MCHC, mean corpuscular hemoglobin concentration (g/dl); Plt, platelet count (610
4/ml). Data are the
mean 6 SD of four wild-type, four CALM
+/2, and five CALM
2/2 mice. Statistical analysis was carried out using the unpaired t-test. **P,0.01, *P,0.05.
doi:10.1371/journal.pone.0031854.t002
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In this report, we established CALM-deficient mice and showed
that these mice exhibit retarded growth in utero and remain
dwarfed throughout their shortened life-span. CALM-deficient
mice suffer from severe anemia, similar to what has been reported
for fit1 mutant mice [21]. In addition, the maturation of erythroid
precursors was severely impaired in mice lacking CALM. The iron
content of erythroid precursors was lower in CALM-deficient mice
compared to their wild-type littermates. Importantly, those
Figure 3. FACS analyses of erythroblasts at different stages of maturation in wild-type or CALM-deficient mice. (A) Representative flow
cytometry histograms. In 3-week-old mice, erythroblasts at different maturation stages were identified by double staining with FITC-conjugated anti-
TER119 and PE-conjugated anti-CD71 Abs. (B) Representative flow cytometry histograms. Erythroblasts at different maturation stages were identified
by double staining with FITC-conjugated anti-TER119 and APC-conjugated anti-CD44 Abs. Plots of CD44 vs. forward scatter (FSC) for TRE119-positive
cells are shown. (C) Quantification of regions I to IV of (A) (data represent means6SD; n=4). *, P,0.05 vs. control. (D) Quantification of regions I to V
of (B) (data represent means6SD; n=5). *, P,0.05 vs. control.
doi:10.1371/journal.pone.0031854.g003
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The amount of ferritin in CALM-deficient mice was three-times
higher than that in wild-type mice, suggesting that there is an
excess of iron in the plasma of mice deficient in CALM.
It is well established that iron deficiency inhibits erythroid
maturation [26,27,33,34]. Anemia is the most obvious manifesta-
tion of iron deficiency due to the large amount of iron required for
hemoglobin production in developing erythroid cells. Transferrin
receptor 1-deficient mice die during embryogenesis due to the lack of
transferrin-mediated iron uptake [31]. Slc11a2 is the only
transmembrane transporter protein known to be required for iron
entry into cells and is required for normal hemoglobin production
during the development of erythroid precursors. Slc11a2-deficient
mice also exhibit severe anemia after birth [30]. Our results
suggest that iron deficiency in CALM-deficient mice results in
inhibition of erythroid maturation and subsequent anemia.
The question then arises as to which molecule involved in iron
uptake is affected by CALM-deficiency in mice. Transferrin
receptor 1 (TFR1), also known as CD71, is one such candidate
molecule. TFR1 is highly expressed in erythroblasts, and the
uptake of iron-bound transferrin through TFR1 is the main
pathway by which iron enters erythroid precursors [33,34]. It is
also well established that inhibition of this process prevents
erythroid maturation due to iron deficiency [31]. Transferrin is
taken up by cells through clathrin-dependent endocytosis [6,35];
thus, it is likely that impaired transferrin endocytosis in CALM-
deficient mice underlies the inhibition of erythroid maturation.
However, the involvement of CALM in clathrin-dependent
endocytosis of transferrin remains controversial. While one study
has shown that over-expression of full-length CALM and CALM
fragments that contain clathrin-binding domains can block
transferrin endocytosis [15], another study reports that over-
expression of CALM had no effect on transferrin endocytosis [36].
CALM depletion experiments using small inhibitory (si)RNA did
not demonstrate an effect on transferrin endocytosis, although
there was partial inhibition of epidermal growth factor (EGF)
receptor endocytosis [36,37]. Based on these reports, CALM is not
believed to be an essential component of clathrin-associated
endocytosis of transferrin [11,36,37]. The CALM-deficient mice
generated in the current study provided an excellent model system
for probing the role of CALM in clathrin-dependent endocytosis
of transferrin. Transferrin uptake by erythroid cells was analyzed
by FACS, and the results suggested that transferrin uptake is
significantly attenuated in CALM-deficient erythroid cells. We also
established CALM knock-out (KO) MEFs from CALM-deficient
embryos and clearly demonstrated that CALM KO MEFs fail to
Figure 4. CALM is required for normal erythropoiesis. (A) CD45 profile of peripheral blood cells from transplanted mice 9 weeks after
transplantation. (B) FACS analyses of erythroblasts at different maturation stages from transplanted mice using anti-TER119 and anti-CD71 Abs. (C)
Peripheral blood smears from mice transplanted with fetal liver cells from either wild-type littermates or CALM-deficient embryos. Scale bar, 50 mm. In
A, B, and C, (+/+) and (2/2) represent host mice transplanted with cells from wild-type and CALM-deficient mice, respectively.
doi:10.1371/journal.pone.0031854.g004
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identified by double staining with APC-conjugated anti-TER119 and PE-conjugated anti-CD71 Abs (upper). These cells were simultaneously loaded
with calcein (CA-AM) for the LIP assay (lower). (B) Quantification of CA-negative fractions in regions I to IV of (A) (data represent means6SD; n=3). (C)
Representative flow cytometry histograms of E14.5 fetal liver cells. Erythroblasts at different stages of maturation were identified by double staining
with APC-conjugated anti-TER119 and PE-conjugated anti-CD71 Abs. Cells were treated for 1 h with the iron chelator DFO, loaded with CA-AM for
10 min, and then analyzed. (D) Representative fluorescence (FL1-high) histograms of CA-stained cells treated with or without DFO are shown, along
with mean fluorescence intensity (MFI). (E) The LIP is represented by the difference in MFI between DFO-treated and -untreated cells (data represent
means6SD; n=3). *, P,0.05 vs. control. In A, B, C and D, (+/+) and (2/2) represent wild-type and CALM-deficient mice, respectively.
doi:10.1371/journal.pone.0031854.g005
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deficient erythroid cells. Single cell suspensions from fetal livers were analyzed as described in Materials and Methods. Transferrin uptake was
normalized to the ratio of mean anti-CD71 (transferrin receptor 1) fluorescence intensity between wild-type and CALM-deficient cells to control for
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involved in transferrin endocytosis in erythroid cells and MEFs. In
addition, the LIP in erythroid cells, which represents a crossroads
of iron metabolic pathways, was determined. The iron content of
erythroid cells was lower in CALM-deficient mice compared to
their wild-type littermates. Our results collectively suggest that
defective transferrin endocytosis in CALM-deficient mice results in
altered distribution of iron in the body and inhibition of erythroid
maturation, resulting in an anemic state.
Discrepancies between the results obtained by RNA interfer-
ence using cell lines and those derived from genetic models in mice
are reported for several proteins involved in clathrin-mediated
endocytosis, such as SMAP1, epsin1 and epsin 2 [36–42]. In these
cases, impaired endocytosis was reported in response to the
inhibition of protein expression by siRNA but not in gene-deficient
mice. As suggested previously for other proteins, differences
between our results and those of previous studies in terms of the
involvement of CALM in transferrin endocytosis could be due to
incomplete inhibition of protein expression using siRNA [36,37].
CALM was originally isolated as a component of the CALM/
AF10 fusion gene, which results from the chromosomal translo-
cation t(10;11)(p13;q14) [16]. In a murine bone marrow
transplantation model, expression of CALM/AF10 in primary
murine bone marrow cells results in the development of an
aggressive form of leukemia [17,18]. These data suggest that
CALM or clathrin-mediated endocytosis may play an important
role in leukemogenesis. Recent reports demonstrate that the
clathrin-binding domain of CALM is important for leukemogenesis
by CALM-AF10 [43,44]. The fact that deletion of CALM resulted
in disruption of clathrin-mediated endocytosis of transferrin
suggests that clathrin-mediated endocytosis may play a role in
leukemogenesis. A number of other proteins that are important for
hematopoiesis are substrates of clathrin-mediated endocytosis
[45–47]. Thus, the CALM-deficient mice and MEFs established
in this study will be useful tools for elucidating the involvement of
CALM in leukemogenesis.
CALM plays an important role in the central nervous system
(CNS). For example, reduction of CALM expression in hippo-
campal neurons results in dendritic dystrophy [48]. Although the
current study focused mainly on hematological changes in CALM-
deficient mice, we did some preliminary analyses of the mouse
brain to assess any pathology of the neural system. Although there
were no differences observed in the hippocampus and dentate
gyrus between wild-type and CALM-deficient mice, there was
significant atrophy of the cortex and ventricles were markedly
enlarged in CALM -deficient mice (data not shown). A detailed
analysis of these observations will be reported elsewhere.
In summary, our analysis of CALM-deficient mice supports an
important role for CALM in erythroid maturation and transferrin
incorporation via clathrin-dependent endocytosis. A number of
other proteins that are important for hematopoiesis are also
incorporated into cells via clathrin-mediated endocytosis [45–47];
thus, CALM-deficient mice and MEFs established from these mice
should prove to be useful for studying the involvement of CALM
in other important hematopoietic processes. Several such exper-
iments are currently underway in our laboratory.
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